Later, Bae et al. suggested SLAMF7239–247 as SLAMF7-specific HLA-A2 peptide capable of activating cytotoxic T lymphocytes and inducing specifically the lysis of the primary MM cells and HLA-A2+-CS1+ MM cell line [75] (Table 3). This evidence concerns the gene SLAMF7 and Miyoshi myopathy.